Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 15, 04 December 2023
Open
Access | Article
Verbal memory deficits in schizophrenia
* Author to whom correspondence should be addressed.
Abstract
Schizophrenia is a severe mental disorder characterized by multifactorial etiology, encompassing genetic and environmental risk factors, as well as structural brain abnormalities. The disorder manifests through a spectrum of symptoms, broadly categorized as positive, negative, and cognitive impairments. Among these cognitive deficits, verbal memory impairment stands out as a substantial and pivotal symptom of schizophrenia, significantly predicting future functional outcomes. This deficit primarily arises from a substantial decline in encoding ability coupled with a mild increase in forgetting rate. To assess the extent of this impairment, word list learning tasks are commonly employed. Research has established a clear association between verbal memory deficits and alterations in hippocampal volume, aberrant brain responses, and anomalies in spontaneous brain activity. Although targeted pharmacological interventions for verbal memory deficits are currently lacking, medications aimed at enhancing cognitive function, such as aripiprazole, present a viable interim option. Future research endeavors should focus on exploring the fundamental aspects of memory and brain structure and function, while incorporating advanced techniques like repetitive transcranial magnetic stimulation (rTMS) into investigations of verbal memory deficits. Additionally, the development of animal models capable of simulating verbal memory deficits holds promise for advancing our understanding of this critical aspect of schizophrenia.
Keywords
Schizophrenia, Cognitive Impairments, Verbal Memory Deficits, Clinical Treatment
References
1. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci. 2010 Sep 30;12(3):271–87.
2. Lavretsky H. History of Schizophrenia as A Psychiatric Disorder. In: Mueser KT, Jeste DV, editors. Clinical Handbook of Schizophrenia. Guilford Publications; 2008.
3. Saha S, Chant D, Welham J, McGrath J. A Systematic Review of the Prevalence of Schizophrenia. Hyman SE, editor. PLoS Med. 2005 May 31;2(5):e141.
4. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry. 2000 Feb;47(3):210–20.
5. Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Dis Primer. 2015 Nov 12;1(1):15067.
6. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D, et al. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc. 1995 Jan;1(1):88–99.
7. McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry [Internet]. 2023 Jan 23 [cited 2023 Jun 29]; Available from: https://www.nature.com/articles/s41380-023-01949-9
8. Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019 Jun;18(2):146–61.
9. Kharawala S, Hastedt C, Podhorna J, Shukla H, Kappelhoff B, Harvey PD. The relationship between cognition and functioning in schizophrenia: A semi-systematic review. Schizophr Res Cogn. 2022 Mar;27:100217.
10. Khamroev SB. Characteristics of cognitive impairment in schizophrenia. Res J Trauma Disabil Stud. 2023 Apr;2(4):61–70.
11. Gebreegziabhere Y, Habatmu K, Mihretu A, Cella M, Alem A. Cognitive impairment in people with schizophrenia: an umbrella review. Eur Arch Psychiatry Clin Neurosci. 2022 Oct;272(7):1139–55.
12. Duan X, He C, Ou J, Wang R, Xiao J, Li L, et al. Reduced Hippocampal Volume and Its Relationship With Verbal Memory and Negative Symptoms in Treatment-Naive First-Episode Adolescent-Onset Schizophrenia. Schizophr Bull. 2021 Jan 23;47(1):64–74.
13. Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: Characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res. 2008 Oct;105(1–3):78–85.
14. Toulopoulouand T, Murray RM. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother. 2004 Jan;4(1):43–52.
15. Antoniades M, Schoeler T, Radua J, Valli I, Allen P, Kempton MJ, et al. Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis. Neurosci Biobehav Rev. 2018 Mar;86:166–75.
16. Eyler LT, Jeste DV, Brown GG. Brain response abnormalities during verbal learning among patients with schizophrenia. Psychiatry Res Neuroimaging. 2008 Jan;162(1):11–25.
17. Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, et al. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia. Front Psychiatry. 2020 Aug 31;11:832.
18. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci. 2011 Feb 15;108(7):3017–22.
19. Liu C, Han T, Xu Z, Liu J, Zhang M, Du J, et al. Modulating Gamma Oscillations Promotes Brain Connectivity to Improve Cognitive Impairment. Cereb Cortex. 2022 Jun 7;32(12):2644–56.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-193-3
- ISBN (Online)
- 978-1-83558-194-0
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/15/20240466
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited